Results 11 to 20 of about 65,584 (272)

Multiple endocrine neoplasia type 4: a new member of the MEN family

Endocrine Connections, 2022
Objective Multiple endocrine neoplasia type 4 (MEN4) is caused by a CDKN1B germline mutation first described in 2006. Its estimated prevalence is less than one per million. The aim of this study was to define the disease characteristics.
H. Singeisen, M. Renzulli, V. Pavlicek, P. Probst, F. Hauswirth, M. K. Muller, Magdalene Adamczyk, Achim Weber, R. Kaderli, P. Renzulli   +9 more
semanticscholar   +1 more source

Importance of early detection in multiple endocrine neoplasia type 1: Clinical insights and future directions. [PDF]

World J Gastrointest Oncol
Ren MJ, Zhang ZL, Tian C, Liu GQ, Zhang CS, Yu HB, Xin Q.   +6 more
europepmc   +2 more sources

Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1

International Journal of Molecular Sciences, 2021
Pancreatic neuroendocrine tumors (pNETs) are a rare group of cancers accounting for about 1–2% of all pancreatic neoplasms. About 10% of pNETs arise within endocrine tumor syndromes, such as Multiple Endocrine Neoplasia type 1 (MEN1). pNETs affect 30–80%
F. Marini, F. Giusti, F. Tonelli, M. Brandi   +3 more
semanticscholar   +1 more source

Lady Surrounded by Multiple Endocrine Neoplasia (MEN) [PDF]

Bengal Physician Journal, 2023
Secondary adrenal insufficiency (SAI) had been diagnosed in a nondiabetic lady with recurrent hypoglycemia having low morning cortisol and low-normal adrenocorticotropic hormone.
Partha Pratim Chakraborty, Spandan Saha, Sriparna Das, Saumik Datta   +3 more
doaj   +1 more source

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

The Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth, Bruce Robinson, Valentina Boni, Daniel S.W. Tan, Caroline McCoach, Erminia Massarelli, Lisa M. Hess, Min‐Hua Jen, Jennifer Kherani, Elizabeth Olek, Vivek Subbiah   +10 more
wiley   +1 more source

Multiple Endocrine Neoplasia Type 1: Latest Insights.

Endocrine reviews, 2020
Multiple Endocrine Neoplasia Type 1 (MEN1), a rare tumor syndrome that is inherited in an autosomal dominant pattern, is continuing to raise great interest for endocrinology, gastroenterology, surgery, radiology, genetics and molecular biology ...
M. Brandi, S. Agarwal, N. Perrier, K. Lines, G. Valk, R. Thakker   +5 more
semanticscholar   +1 more source

Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome – An International Consensus Statement

Neuroendocrinology, 2020
The better understanding of the biological behavior of multiple endocrine neoplasia type 1 (MEN1) organ manifestations and the increase in clinical experience warrant a revision of previously published guidelines.
B. Niederle, A. Selberherr, D. Bartsch, M. Brandi, G. Doherty, M. Falconi, P. Goudet, T. Halfdanarson, Tetsuhide Ito, R. Jensen, A. Larghi, Lingaku Lee, K. Öberg, M. Pavel, A. Perren, S. Sadowski, F. Tonelli, F. Triponez, G. Valk, D. O’Toole, D. Scott-Coombes, R. Thakker, G. Thompson, G. Treglia, B. Wiedenmann   +24 more
semanticscholar   +1 more source

Multiple Endocrine Neoplasia

Handbook of Tumor Syndromes, 2020
Multiple endocrine neoplasia is a group of disorders that affect the body's network of hormone-producing glands called the endocrine system. Hormones are chemical messengers that travel through the bloodstream and regulate the function of cells and ...
Carl Philpott, P. Tassone, M. Clark
semanticscholar   +1 more source

Pituitary tumors in patients with MEN1 syndrome

Clinics, 2012
We briefly review the characteristics of pituitary tumors associated with multiple endocrine neoplasia type 1. Multiple endocrine neoplasia type 1 is an autosomal-dominant disorder most commonly characterized by tumors of the pituitary, parathyroid ...
Luis V. Syro, Bernd W. Scheithauer, Kalman Kovacs, Rodrigo A. Toledo, Francisco J. Londoño, Leon D. Ortiz, Fabio Rotondo, Eva Horvath, Humberto Uribe   +8 more
doaj   +1 more source

Multiple endocrine neoplasia 2: an overview

Therapeutic Advances in Chronic Disease, 2022
This review article discusses the diagnosis and treatment of patients with multiple endocrine neoplasia type 2 (MEN2). The most common tumors associated with MEN2 are those of the parathyroid, thyroid, and adrenal glands.
B Saravana-Bawan, JD Pasternak
doaj   +1 more source